Feedback
Mucopolysaccharidosis Type 1, NRE (Sensi-Pro) Quantitative, Serum or Plasma (INACTIVE as of 10/05/15)
2007496
Ordering Recommendation
Mnemonic
MPSI NRE S
Methodology
Liquid Chromatography-Tandem Mass Spectrometry
Performed
Mon
Reported
7-14 days
New York DOH Approval Status
Specimens from New York clients will be sent out to a New York DOH approved laboratory, if possible.
ARUP Consult®
Disease Topics
Specimen Required
Patient Preparation
 
Collect
Plain red, Serum separator, or EDTA (lavender) tube. 
Specimen Preparation
Transfer 500 uL serum or plasma to ARUP Standard Transport Tube and freeze immediately. (Min: 250 uL) 
Storage/Transport Temperature
Frozen. 
Unacceptable Conditions
Plasma collected in Heparin (green) tubes. Refrigerated specimens received in lab more than 24 hours after collection. 
Remarks
 
Stability
Ambient: Unacceptable; Refrigerated: Unacceptable; Frozen: 1 month (avoid repeated freeze/thaw cycles) 
Reference Interval
By Report
Interpretive Data
Refer to Report

Compliance Statement B: This test was developed and its performance characteristics determined by ARUP Laboratories. The U.S. Food and Drug Administration has not approved or cleared this test; however, FDA clearance or approval is not currently required for clinical use. The results are not intended to be used as the sole means for clinical diagnosis or patient management decisions.

Note
CPT Code(s)
83864
Components
Component Test Code*Component Chart NameLOINC
2007494MPSI - Heparan Sulfate NRE, Serum/Plasma
* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, please click the sidebar link to access the Interface Map.
Aliases
  • Heparan Sulfate NRE, Serum/Plasma
  • Heparan Sulfate NRE, Urine
  • HS serum or plasma non reducing end assay
  • HS urine non reducing end assay
  • MPS I
  • MPS Type 1